CAAP® – Building Companies

By mmuise
Description:

OBIO® Capital Access Advisory Program (CAAP®), a 9-month structured program for health science companies is designed to operate downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. CAAP® covers three fundamental business themes:
1. Business strategic planning & increasing the ROI for investors;
2. Advanced fundraising strategies & financial modeling;
3. Closing an investment round.


Comments on Funding:

No funding provided.

Deadline: Rolling deadline
Eligibility:

Applicants must be:

  • health science companies;
  • starting to raise Series A financing in Q4 2023 to 2024 timeframe.
Application Steps:

No specific steps have been identified.

Documentation Needed:

No specific documentation has been identified.

Other Things to Note:

For further details, please contact:
Jack Lee
Director, Technology Commercialization
416.848.6839, ext. 102

Program Contact: https://www.obio.ca/obiocaap
About the author
mmuise